CORRECT: AstraZeneca Says FDA Committee Vote Positive For Movantik
(An item published at 0717 BST misspelled the name Movantik. The correct version follows.) LONDON (Alliance News) - AstraZeneca PLC said late Thursday the US Food and Drug Administration's Analgesic Drug Products Advisory Committee has recommended the FDA not require cardiovascular outcomes Read More